For the quarter ending 2025-12-31, IMVT has $1,052,392K in assets. $66,257K in debts. $994,525K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 994,525 | 521,870 | 598,912 | |
| Accounts receivable | 1,643 | 1,970 | 1,936 | |
| Prepaid expenses and other current assets | 46,771 | 49,706 | 50,915 | |
| Total current assets | 1,042,939 | 573,546 | 651,763 | |
| Property and equipment, net | 531 | 632 | 737 | |
| Other assets | 8,922 | 8,781 | 8,940 | |
| Total assets | 1,052,392 | 582,959 | 661,440 | |
| Accounts payable | 8,616 | 6,916 | 7,843 | |
| Accrued expenses and other current liabilities | 57,641 | 56,338 | 45,057 | |
| Total current liabilities | 66,257 | 63,254 | 52,900 | |
| Total liabilities | 66,257 | 63,254 | 52,900 | |
| Preferred stock-Series APreferred Stock | 0 | 0 | 0 | |
| Preferred stock-Preferred Stock Excluding Series APreferred Stock | 0 | 0 | 0 | |
| Common stock, par value 0.0001 per share, 500,000,000 shares authorized, 203,316,885 shares issued and outstanding at december31, 2025 and 500,000,000 shares authorized, 170,111,593 shares issued and outstanding at march31, 2025 | 20 | 17 | 16 | |
| Additional paid-in capital | 2,582,191 | 2,004,876 | 1,966,923 | |
| Accumulated other comprehensive income | 1,197 | 1,450 | 1,737 | |
| Accumulated deficit | -1,597,273 | -1,486,638 | -1,360,136 | |
| Total stockholders equity | 986,135 | 519,705 | 608,540 | |
| Total liabilities and stockholders equity | 1,052,392 | 582,959 | 661,440 | |
Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT)